login
login
Image header Agence Europe
Europe Daily Bulletin No. 8087
Contents Publication in full By article 17 / 33
GENERAL NEWS / (eu) eu/health

Commission authorises marketing of new medicine for treating certain forms of leukaemia

Brussels, 08/11/2001 (Agence Europe) - The European Commission has authorised, by centralised procedure, the Community marketing of a new medicine for the treatment of certain forms of leukaemia. As it is an orphan medicine, the product will benefit from ten year protection on the EU15 market. Already authorised and marketed in the United States and Switzerland since 26 June, Glivec has been developed by the Novartis laboratory, which is currently making new trials with a view to determining...

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS